RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/27561390http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/27561390http://www.w3.org/2000/01/rdf-schema#comment"The tumour suppressor CYLD is a deubiquitinase previously shown to inhibit NF-κB, MAP kinase and Wnt signalling. However, the tumour suppressing mechanisms of CYLD remain poorly understood. Here we show that loss of CYLD catalytic activity causes impaired DNA damage-induced p53 stabilization and activation in epithelial cells and sensitizes mice to chemical carcinogen-induced intestinal and skin tumorigenesis. Mechanistically, CYLD interacts with and deubiquitinates p53 facilitating its stabilization in response to genotoxic stress. Ubiquitin chain-restriction analysis provides evidence that CYLD removes K48 ubiquitin chains from p53 indirectly by cleaving K63 linkages, suggesting that p53 is decorated with complex K48/K63 chains. Moreover, CYLD deficiency also diminishes CEP-1/p53-dependent DNA damage-induced germ cell apoptosis in the nematode Caenorhabditis elegans. Collectively, our results identify CYLD as a deubiquitinase facilitating DNA damage-induced p53 activation and suggest that regulation of p53 responses to genotoxic stress contributes to the tumour suppressor function of CYLD."xsd:string
http://purl.uniprot.org/citations/27561390http://purl.org/dc/terms/identifier"doi:10.1038/ncomms12508"xsd:string
http://purl.uniprot.org/citations/27561390http://purl.uniprot.org/core/author"Schell M."xsd:string
http://purl.uniprot.org/citations/27561390http://purl.uniprot.org/core/author"Schumacher B."xsd:string
http://purl.uniprot.org/citations/27561390http://purl.uniprot.org/core/author"Komander D."xsd:string
http://purl.uniprot.org/citations/27561390http://purl.uniprot.org/core/author"Buttner R."xsd:string
http://purl.uniprot.org/citations/27561390http://purl.uniprot.org/core/author"Ermolaeva M.A."xsd:string
http://purl.uniprot.org/citations/27561390http://purl.uniprot.org/core/author"Adam A."xsd:string
http://purl.uniprot.org/citations/27561390http://purl.uniprot.org/core/author"Pasparakis M."xsd:string
http://purl.uniprot.org/citations/27561390http://purl.uniprot.org/core/author"Thomas R.K."xsd:string
http://purl.uniprot.org/citations/27561390http://purl.uniprot.org/core/author"Fernandez-Majada V."xsd:string
http://purl.uniprot.org/citations/27561390http://purl.uniprot.org/core/author"Welz P.S."xsd:string
http://purl.uniprot.org/citations/27561390http://purl.uniprot.org/core/author"Dietlein F."xsd:string
http://purl.uniprot.org/citations/27561390http://purl.uniprot.org/core/date"2016"xsd:gYear
http://purl.uniprot.org/citations/27561390http://purl.uniprot.org/core/name"Nat Commun"xsd:string
http://purl.uniprot.org/citations/27561390http://purl.uniprot.org/core/pages"12508"xsd:string
http://purl.uniprot.org/citations/27561390http://purl.uniprot.org/core/title"The tumour suppressor CYLD regulates the p53 DNA damage response."xsd:string
http://purl.uniprot.org/citations/27561390http://purl.uniprot.org/core/volume"7"xsd:string
http://purl.uniprot.org/citations/27561390http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/27561390
http://purl.uniprot.org/citations/27561390http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/27561390
http://purl.uniprot.org/uniprot/#_E9PZP3-mappedCitation-27561390http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/27561390
http://purl.uniprot.org/uniprot/#_A6YM30-mappedCitation-27561390http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/27561390
http://purl.uniprot.org/uniprot/#_A0A158SIS7-mappedCitation-27561390http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/27561390
http://purl.uniprot.org/uniprot/#_A0A5Q0MU23-mappedCitation-27561390http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/27561390